Abstract
Interpretation is more easily said than done. The task itself is complex and decisions may be difficult (Part III). Furthermore, the intent of the expert pathologist, set forth in writing, is not always decipherable by clinicians and patients. Also, there is dawning recognition that the opinions of different experts are not necessarily in harmony, whether in regard to the interpretation of the basic H&E stained material, or the interpretation and significance of IHC biomarker results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cartun R, Taylor CR. Techniques of immunohistochemistry: principles, pitfalls and standardization. In: Dabbs DJ, editor. Comprehensive diagnostic immunohistochemistry. 5th ed. Amsterdam: Elsevier; 2018.
Castle WB. Harv Med Alumni Bull. 1955;29:18.
College of American Pathologists Accreditation Checklists. 2020. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwizm5r1x4XvAhXRIDQIHQcLBDYQFjABegQIAhAD&url=https%3A%2F%2Fdocuments.cap.org%2Fdocuments%2Fcap-accreditation-checklists.pdf&usg=AOvVaw2x4EVwmVwK98oVt8QiUyZG
Dabbs DJ, editor. Comprehensive diagnostic immunohistochemistry. 5th ed. Amsterdam: Elsevier; 2018.
FDA. Guidance for submission of immunohistochemistry applications to the food and drug administration—Final guidance for industry. original issuance 1998. 1998, 2021. https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/guidance-submission-immunohistochemistry-applications-food-and-drug-administration-final-guidance. accessed Feb 2021.
Fitzgibbons PL, Bradley LA, Fatheree LA, et al. Principles of analytic validation of immunohistochemical assays. Arch Pathol. 2014;138:1432–43.
Foucar E, Foucar MK. Error in anatomic pathology. In: Foucar MK, editor. Bone marrow pathology. 2nd ed. Chicago: ASCP Press; 2000.
Leong AS. Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl Immunohistochem Mol Morph. 2004;12:1–7.
Leong AS, Leong TY. Standardization in immunohistochemistry. Methods Mol Biol. 2011;724:37–68.
Nielsen S. External quality assessment for immunohistochemistry: experiences from NordiQC. Biotech Histochem. 2015;90:1–10. https://doi.org/10.3109/10520295.2015.1033462.
O’Leary TJ. Standardization in immunohistochemistry. Appl Immunohistochem Mol Morph. 2001;9:3–8.
Phillips T, Millett MM, Zhang X, Jansson M, Cleveland R, Simmons P, Cherryholmes G, Carnahan J, William J, Spaulding B, Satnick IR, Inzuna HD, Taylor CR, Cogswell J, Novotny J, Oroudjev E, Winther H. Development of a diagnostic programmed cell death 1-ligand 1 immunohistochemistry assay for Nivolumab therapy in melanoma. Appl Immunohistochem Mol Morph. 2018;26:6–12.
Phillips T, Simmons P, Inzunza HD, Cogswell J, Novotny J, Taylor CR, Zhang X. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non small cell lung cancer. Appl Immunohistochem Mol Morph. 2015;23:541–9. https://doi.org/10.1097/PAI.0000000000000256.
Renshaw AA, Gould EW. Measuring errors in surgical pathology in real-life practice. Defining what does and does not matter. Am J Clin Pathol. 2007;127:144–52.
Rhodes A, Jasani B, Anderson E, Dodson AR, Balaton AJ. Evaluation of Her2/neu immunohistochemical assays sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol. 2002;118:408–17.
Rhodes A, Jasani B, Balaton AJ, Miller KD. Immunohistochemical demonstration of estrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol. 2000;53:292–301.
Simental-Pizarro RG, Klipfel N, Taylor CR. Tumors of unknown origin. In: Cheng L, editor. Essentials of anatomic pathology. 4th ed. New York: Humana Press/Springer; 2016.
Taylor CR. Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the biological stain commission, June, 1991. Biotech Histochem. 1992;67:110–7.
Taylor CR. Report from the biological stain commission: FDA issues final rule for classification/reclassification of immunochemistry (IHC) reagents and kits. Biotech Histochem. 1998;73:175–7.
Torlakovic EE, Nielsen S, Vyberg M, Taylor CR. Getting controls under control—the time is now for immunohistochemistry. J Clin Path. 2015;68:1–4. https://doi.org/10.1136/jclinpath-2014-202705.
Vyberg M, Nielsen S. Proficiency testing in immunohistochemistry—experiences from nordic immunohistochemical quality control (NordiQC). Virchows Arch. 2016;468(1):19–29. https://doi.org/10.1007/s00428-015-1829-1.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jasani, B., Huss, R., Taylor, C.R. (2021). Post-Analytic Phase: Interpretation, Scoring and Reporting of Biopsy Results. In: Precision Cancer Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-84087-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-84087-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84086-0
Online ISBN: 978-3-030-84087-7
eBook Packages: MedicineMedicine (R0)